ClinicalTrials.Veeva

Menu

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation (VORTAL)

R

Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov

Status

Enrolling

Conditions

Liver Transplant; Complications
Liver Cirrhosis

Treatments

Procedure: Liver transplantation

Study type

Observational

Funder types

Other

Identifiers

NCT06169592
05122023

Details and patient eligibility

About

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age over 18 years and up to 70 years;
  • Signed informed consent for inclusion to the study;
  • End stage liver cirrhosis.

Exclusion criteria

  • Pregnancy;
  • Extrahepatic factors influencing systemic hemostasis;
  • Concomitant hematological diseases affecting the hemostatic system;
  • Severe concomitant disorders.

Trial design

30 participants in 1 patient group

liver transplant group
Treatment:
Procedure: Liver transplantation

Trial contacts and locations

1

Loading...

Central trial contact

Azam Babadjanov, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems